Clinical Trial Update: Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Origin [NA]

View source ↗

Summary

A clinical trial evaluating the CEST MRI sequence for characterizing radionecrosis in brain metastases originating from lung cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Lung Cancer

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Brain Metastases, Radionecrosis | NA | Status: RECRUITING